Joshua Reed - Net Worth and Insider Trading
Joshua Reed Net Worth
The estimated net worth of Joshua Reed is at least $170,284 dollars as of 2024-11-13. Joshua Reed is the CFO of Aldeyra Therapeutics Inc and owns about 35,774 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $170,284. Details can be seen in Joshua Reed's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua Reed has not made any transactions after 2019-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joshua Reed
Joshua Reed Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua Reed owns 3 companies in total, including Aldeyra Therapeutics Inc (ALDX) , Scholar Rock Holding Corp (SRRK) , and Omega Therapeutics Inc (OMGA) .
Click here to see the complete history of Joshua Reed’s form 4 insider trades.
Insider Ownership Summary of Joshua Reed
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-05 | Chief Financial Officer |
| SRRK | Scholar Rock Holding Corp | 2022-05-26 | director |
| OMGA | Omega Therapeutics Inc | 2022-05-23 | Chief Financial Officer |
Joshua Reed Latest Holdings Summary
Joshua Reed currently owns a total of 1 stock. Joshua Reed owns 35,774 shares of Aldeyra Therapeutics Inc (ALDX) as of September 5, 2019, with a value of $170,284.
Latest Holdings of Joshua Reed
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-05 | 35,774 | 4.76 | 170,284 |
Holding Weightings of Joshua Reed
Joshua Reed Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua Reed has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 3,200 shares on September 5, 2019, which cost Joshua Reed around $15,072.
Insider Trading History of Joshua Reed
- 1
Joshua Reed Trading Performance
GuruFocus tracks the stock performance after each of Joshua Reed's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Reed is -4.36%. GuruFocus also compares Joshua Reed's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Reed within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua Reed's insider trading performs compared to the benchmark.
Performance of Joshua Reed
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.68 | | | | | |
| Relative Return to S&P 500(%) | 12.49 | | | | | |
Joshua Reed Ownership Network
Ownership Network List of Joshua Reed
Ownership Network Relation of Joshua Reed
Joshua Reed Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Joshua Reed is the Chief Financial Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Joshua Reed made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Joshua Reed Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua Reed. You might contact Joshua Reed via mailing address: C/o Aldeyra Therapeutics, Inc., 131 Hartwell Avenue, Suite 320, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
